Who is sponsoring NCT04656509?

NCT04656509 is sponsored by University of Texas at Austin.

What drugs are being tested in NCT04656509?

Interventions in NCT04656509: 4-s sprint inertial load training.

What condition does NCT04656509 study?

NCT04656509 studies Cardiovascular Fitness.

Is NCT04656509 still recruiting?

NCT04656509 is currently completed. Last updated 9 December 2020.

Last reviewed 2020-12-09 · How we verify

NCT04656509

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Short Duration High-intensity Interval Training on Peak Oxygen Consumption

Completed NA Last updated 9 December 2020

What this trial tests

NA trial testing 4-s sprint inertial load training in Cardiovascular Fitness in 11 participants. Completed in 24 April 2020.

Timeline

1 April 2019

Primary endpoint
31 March 2020

24 April 2020

Quick facts

Lead sponsor	University of Texas at Austin
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	11
Start date	1 April 2019
Primary completion	31 March 2020
Estimated completion	24 April 2020
Sites	1 location across United States

Drugs / interventions tested

4-s sprint inertial load training

Conditions studied

Cardiovascular Fitness — all drugs for Cardiovascular Fitness →

Sponsor

University of Texas at Austin

Who can join

Adults 18 to 49, any sex, with Cardiovascular Fitness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High-intensity interval training (HIIT) is an effective tool to improve cardiovascular fitness and maximal anaerobic power. Different methods of HIIT have been studied but the effect of a maximal effort cycling and very short exercise time (i.e., 4-s) with short recovery time (15-30 s) and a high number of repetitions (i.e., 30 bouts) is unknown.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Texas at Austin trials

Trials by the same sponsor.

NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04656509 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
Last refreshed: 9 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04656509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing